Akanda Corp (AKAN)
2.35
0.00 (0.00%)
USD |
NASDAQ |
Jun 27, 10:25
Akanda Shareholders Equity (Quarterly): -3.829M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.829M |
| June 30, 2023 | 21.65M |
| December 31, 2022 | 26.90M |
| June 30, 2022 | 34.64M |
| Date | Value |
|---|---|
| December 31, 2021 | -2.201M |
| September 30, 2021 | 18.78M |
| December 31, 2020 | -5.032M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.032M
Minimum
Dec 2020
34.64M
Maximum
Jun 2022
12.99M
Average
18.78M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| Verona Pharma PLC | 224.99M |
| NuCana PLC | 12.79M |
| Autolus Therapeutics PLC | 582.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.84M |
| Total Liabilities (Quarterly) | 12.67M |
| Debt to Equity Ratio | -1.009 |
| Current Ratio | 0.1775 |
| Net Debt Paydown Yield | -0.41% |